Efficay of cefiderocol as salvage therapy in tricuspid endocarditis due to multidrug-resistant <i>Acinetobacter baumannii</i> during end-stage renal disease. [PDF]
Mastroianni A, Greco S.
europepmc +1 more source
<i>Stenotrophomonas maltophilia</i> in the Antimicrobial Resistance Era: Species-Complex Taxonomy, Pathogenesis, Evolving Therapeutic Priorities, and Genomic Surveillance. [PDF]
Sun R, Cao X, Sun Q.
europepmc +1 more source
Emergence of a novel NDM-4-producing <i>Citrobacter freundii</i> complex species in a complicated urinary tract infection treated with cefiderocol. [PDF]
Boehm C +4 more
europepmc +1 more source
Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). [PDF]
Sader HS +5 more
europepmc +1 more source
Antibiotics and antibiotic resistance race: a chronicle of antibiotic discovery against Gram-negative bacteria during 2001-2020: way forward. [PDF]
Joshi PR +5 more
europepmc +1 more source
Genetic characterization of carbapenem-resistant <i>Klebsiella pneumoniae</i> bloodstream isolates with reduced susceptibility to cefiderocol. [PDF]
Wang M, Wu X, Yuan N, Li L, Zhang Z.
europepmc +1 more source
<i>In vitro</i> activity and clinical use of cefiderocol against <i>Achromobacter xylosoxidans</i> (Review). [PDF]
Giovagnorio F +7 more
europepmc +1 more source
Human ex vivo comparison of Escherichia coli and Pseudomonas aeruginosa lipopolysaccharide-induced immune responses and cefiderocol effects in whole blood. [PDF]
Pracher L +4 more
europepmc +1 more source
Phenotypic and biochemical characterization of the class C β-lactamase, PAC-1. [PDF]
Raro OHF +7 more
europepmc +1 more source
<i>In vitro</i> activity of zosurabalpin against a global set of carbapenem-resistant-<i>A. baumannii</i> clinical isolates. [PDF]
Mancini S +13 more
europepmc +1 more source

